What Is The Current and Historic Market Size Analysis Of The Tylosin Market?
The tylosin market has seen considerable growth due to a variety of factors.
• The tylosin market has grown strongly in recent years. It will increase from $0.74 billion in 2024 to $0.79 billion in 2025, at a CAGR of 6.0%.
This growth is attributed to the expansion of livestock production, the use of antibiotic growth promoters (AGPs), increasing veterinary health awareness, government regulations, and the growing prevalence of livestock diseases.
What Are The Predictions for The Tylosin Market in the Coming Years?
The tylosin market is expected to maintain its strong growth trajectory in upcoming years.
• The tylosin market is expected to expand significantly, reaching $0.98 billion by 2029, with a CAGR of 5.7%.
The growth can be attributed to factors like increased global meat consumption, a focus on animal welfare, the growth of livestock farming in emerging markets, regulatory changes regarding antibiotic use, and a demand for organic and antibiotic-free meat. Key trends include rising demand for antibiotic alternatives, stricter regulations, precision livestock farming advancements, and expansion of veterinary services.
Which Drivers Are Accelerating Growth In The Tylosin Market?
The tylosin market's expansion is projected to be powered by the upsurge in meat production. The term meat production refers to the breeding, slaughtering, and processing of animals in order to procure meat for human use. The augment in meat production is attributable to customer preferences for nutritious and ethically obtained food items, coupled with concerns about the welfare of animals and environmental sustainability. Tylosin is frequently used in animal farming as an antibiotic to address bacterial infections like respiratory illnesses and digestive problems, and in certain areas, it is used as a growth enhancer. For example, in February 2024, the Department for Environmental Food and Rural Affairs, a government department in the UK, reported that the total meat production in the US had reached 4.2 million tons in 2022, confirming an 18% rise from ten years prior. In addition, the production of red meat, particularly mutton and lamb, saw an increase, with the most noteworthy growth rate of 2.9%. Moreover, there was a nominal increase in home-fed production, from 4,178 to 4,182, between 2020 and 2022. Consequently, the mounting demand for healthy livestock is propelling the growth of the tylosin market.
What Are The Core Segments Of The Global Tylosin Market?
The tylosin market covered in this report is segmented –
1) By Type: Tylosin Tartrate, Tylosin Phosphate, Other Types
2) By Application: Animal Feed Additives, Animal Drugs, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers
Pre-Book The Tylosin Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Tylosin Market?
Leading companies in the tylosin market are stepping up their offering of innovative solutions, including tulathromycin injection to expand treatment alternatives for illnesses affecting livestock. Tulathromycin injection, a wide-range antibiotic used in veterinary medication, targets respiratory and other forms of infections in livestock. In May 2022, the US-based pharmaceutical titan, Merck & Co. Inc., introduced Tulathromycin injection (Arovyn), made available in 50, 100, 250, and 500 ml vials. This pharmaceutical product is designed to counter bovine respiratory disease (BRD), foot rot, and pinkeye in cattle, alongside respiratory disease in swine. With its effectiveness against such pathogens as Mannheimia haemolytica, Pasteurella multocida, and Moraxella bovis, tulathromycin presents a budget-friendly treatment alternative for both veterinarians and livestock farmers. However, it should not be used on female dairy cattle aged 20 months or more, and there is a mandatory withdrawal period of 18 days for cattle and five days for swine prior to their slaughter.
Who Are the Key Players In The Tylosin Market?
Major companies operating in the tylosin market are:
• Eli Lilly and Company
• Zoetis Inc.
• Elanco Animal Health Inc.
• Ceva Santé Animale
• Apeloa Pharmaceutical co. Ltd.
• Phibro Animal Health Corporation
• Shandong Lukang Pharmaceutical Co. Ltd.
• Vetoquinol S.A.
• Norbrook Inc.
• Qilu Animal Health Products Co. Ltd.
• Merck & Co. Inc.
• Hebei Veyong Animal Pharmaceutical
• Suanfarma SA
• Huvepharma AD
• Rochem International Inc.
• AdvaCare Pharma
• Ningxia Tairui Pharmaceutical Co. Ltd.
• HangZhou Think Chemical Co. Ltd.
• Vetgen Healthcare Pvt Ltd.
• Anhui Sinotech Industrial
• Pucheng Chia Tai Biochemistry Co Ltd.
• All Chem Bio Sciences
• Nestlife Science Pvt Ltd.
• Sunvet Pharma Private Ltd.
• BOC Sciences
What Are The Regional Insights Into The Tylosin Market?
North America was the largest region in the tylosin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tylosin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
